Included in the formulation
АТХ:A.02.B.X Other antiulcer drugs
Pharmacodynamics:Has an antacid, astringent, spasmolytic and mild laxative effect.
Magnesium carbonate and sodium hydrogen carbonate reduce the acidity of gastric juice and the activity of pepsin.
Bismuth subnitrate has a bactericidal and anti-inflammatory effect, as well as a reparative function, forming a protective film on the gastric mucosa.
Ayr rhizomes and kellin have an antispasmodic effect, the buckthorn bark is a laxative.
Pharmacokinetics:No data.
Indications:- gastritis with high acidity of gastric juice;
- peptic ulcer of the stomach and duodenum.
XI.K20-K31.K25 Stomach ulcer
XI.K20-K31.K26 Duodenal ulcer
XI.K20-K31.K29.7 Gastritis, unspecified
XI.K20-K31.K29.6 Other gastritis
Contraindications:- individual intolerance;
- hypoacid gastritis;
- kidney failure;
- chronic appendicitis;
- enterocolitis;
- pregnancy and breastfeeding;
- children's age (under 18 years).
Pregnancy and lactation:Action category for the fetus by FDA not determined. The drug is contraindicated during pregnancy and the period of breastfeeding.
Dosing and Administration:Inside, after eating, chopping and dissolving the tablet in 1/4 cup warm water. It is prescribed for 1-2 tablets 3 times a day. The duration of treatment is 1-2 months. Repeated course is possible only after consulting a doctor.
Side effects:- increased frequency of stools;
- allergic reactions.
Interaction:Reduces absorption tetracyclines with simultaneous administration.
In combination with other preparations containing bismuth, leads to an increase in the concentration of this substance in the blood.
Interaction with other drugs has not been identified.
Special instructions:As a result of the accumulation of bismuth, the development of encephalopathy is possible with prolonged use of the drug in high doses.
Cal at the time of taking the drug gets a dark green or black color.
It is advisable to use caution when management of vehicles and employment in other potentially hazardous activities,requiring increased concentration of attention and speed of psychomotor reactions, when using the drug.
Admission is no more than 2 months.